![Implications of cardiac markers in risk-stratification and management for COVID-19 patients | Critical Care | Full Text Implications of cardiac markers in risk-stratification and management for COVID-19 patients | Critical Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-021-03555-z/MediaObjects/13054_2021_3555_Fig5_HTML.png)
Implications of cardiac markers in risk-stratification and management for COVID-19 patients | Critical Care | Full Text
![Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time | Journal of the American Heart Association Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/ee82c487-e581-4260-87e1-f9d97293a4f6/jah32295-fig-0001.gif)
Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time | Journal of the American Heart Association
![Implications of cardiac markers in risk-stratification and management for COVID-19 patients | Critical Care | Full Text Implications of cardiac markers in risk-stratification and management for COVID-19 patients | Critical Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-021-03555-z/MediaObjects/13054_2021_3555_Fig6_HTML.png)
Implications of cardiac markers in risk-stratification and management for COVID-19 patients | Critical Care | Full Text
![Point-of-care testing for cardiac markers in acute coronary syndromes and heart failure. | Semantic Scholar Point-of-care testing for cardiac markers in acute coronary syndromes and heart failure. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d6e110bc10916a9dd59a8fa5b9a91e0b15bb10d8/3-Table1-1.png)
Point-of-care testing for cardiac markers in acute coronary syndromes and heart failure. | Semantic Scholar
![Cardiac biomarkers in patients with prostate cancer and cardiovascular disease receiving gonadotrophin releasing hormone agonist vs antagonist | Prostate Cancer and Prostatic Diseases Cardiac biomarkers in patients with prostate cancer and cardiovascular disease receiving gonadotrophin releasing hormone agonist vs antagonist | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41391-020-0264-9/MediaObjects/41391_2020_264_Fig1_HTML.png)